Found: 32
Select item for more details and to access through your institution.
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC).
- Published in:
- APMIS, 2006, v. 114, n. 10, p. 675, doi. 10.1111/j.1600-0463.2006.apm_298.x
- By:
- Publication type:
- Article
Human tetranectin: Methodological and clinical studies.
- Published in:
- APMIS, 1998, v. 106, n. S86, p. 7, doi. 10.1111/j.1600-0463.1998.tb05659.x
- By:
- Publication type:
- Article
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 6, p. 519, doi. 10.1002/1097-0215(20001120)89:6<519::AID-IJC9>3.0.CO;2-#
- By:
- Publication type:
- Article
Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0255142
- By:
- Publication type:
- Article
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.
- Published in:
- Canadian Journal of Surgery, 2023, v. 66, n. 3, p. E310, doi. 10.1503/cjs.017020
- By:
- Publication type:
- Article
Annexin A2 and cancer: A systematic review.
- Published in:
- International Journal of Oncology, 2018, v. 52, n. 1, p. 5, doi. 10.3892/ijo.2017.4197
- By:
- Publication type:
- Article
Use of Tetranectin, CA-125 and Casa to Predict Residual Tumor and Survival at Second- and Third-Look Operations for Ovarian Cancer.
- Published in:
- Acta Oncologica, 1996, v. 35, n. 1, p. 63, doi. 10.3109/02841869609098481
- By:
- Publication type:
- Article
Prognostic Value of Serum Tetranectin in Patients with Metastatic Breast Cancer.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 6, p. 631, doi. 10.3109/02841869309092443
- By:
- Publication type:
- Article
Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0282576
- By:
- Publication type:
- Article
Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases.
- Published in:
- Reproductive Sciences, 2021, v. 28, n. 3, p. 757, doi. 10.1007/s43032-020-00372-7
- By:
- Publication type:
- Article
Paired comparison of the analytical performance between the Oncomine™ Comprehensive Assay v3 and whole-exome sequencing of ovarian cancer tissue.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09715-y
- By:
- Publication type:
- Article
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84953-9
- By:
- Publication type:
- Article
YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-8
- By:
- Publication type:
- Article
Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study.
- Published in:
- APMIS, 2015, v. 123, n. 5, p. 401, doi. 10.1111/apm.12368
- By:
- Publication type:
- Article
Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the ' MALOVA' ovarian cancer study.
- Published in:
- APMIS, 2013, v. 121, n. 12, p. 1177, doi. 10.1111/apm.12071
- By:
- Publication type:
- Article
Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?
- Published in:
- APMIS, 2013, v. 121, n. 1, p. 38, doi. 10.1111/j.1600-0463.2012.02943.x
- By:
- Publication type:
- Article
Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish ' MALOVA' ovarian cancer study.
- Published in:
- APMIS, 2012, v. 120, n. 10, p. 846, doi. 10.1111/j.1600-0463.2012.02913.x
- By:
- Publication type:
- Article
Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study.
- Published in:
- APMIS, 2010, v. 118, n. 8, p. 557, doi. 10.1111/j.1600-0463.2010.02614.x
- By:
- Publication type:
- Article
Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.
- Published in:
- APMIS, 2008, v. 116, n. 5, p. 400, doi. 10.1111/j.1600-0463.2008.00917.x
- By:
- Publication type:
- Article
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1954, doi. 10.3390/cancers14081954
- By:
- Publication type:
- Article
Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5242, doi. 10.3390/cancers13205242
- By:
- Publication type:
- Article
Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5230, doi. 10.3390/cancers13205230
- By:
- Publication type:
- Article
Next Generation Sequencing Technology in the Clinic and Its Challenges.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1751, doi. 10.3390/cancers13081751
- By:
- Publication type:
- Article
Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225249
- By:
- Publication type:
- Article
Robot-assisted surgery in gynecological oncology: current status and controversies on patient benefits, cost and surgeon conditions - a systematic review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 12, p. 10235, doi. 10.1007/s11033-023-08795-6
- By:
- Publication type:
- Article
miRNA Expression in Ovarian Cancer in Fresh Frozen, Formalin-fixed Paraffin-embedded and Plasma Samples.
- Published in:
- In Vivo, 2022, v. 36, n. 4, p. 1591, doi. 10.21873/invivo.12869
- By:
- Publication type:
- Article
A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndrome.
- Published in:
- Clinical Genetics, 1994, v. 45, n. 1, p. 1, doi. 10.1111/j.1399-0004.1994.tb03980.x
- By:
- Publication type:
- Article
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 3, p. 323
- By:
- Publication type:
- Article
Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2387
- By:
- Publication type:
- Article
Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 1, p. 66
- By:
- Publication type:
- Article